SCHEMBL6803555

SCHEMBL6803555

O=c1cc(-c2ccc(O)c(O)c2O)oc2c(O)c(O)ccc12

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.73
▸ KDM4E B2RXH2 4/20 0.73
▸ MAPT P10636 4/20 0.73
▸ HPGD P15428 4/20 0.73
▸ ALOX15 P16050 4/20 0.73
▸ HSD17B10 Q99714 4/20 0.73
▸ CYP2C19 P33261 4/20 0.73
▸ ALDH1A1 P00352 3/20 0.73
▸ MEN1 O00255 3/20 0.73
▸ KMT2A Q03164 3/20 0.73
▸ CYP2C9 P11712 3/20 0.73
▸ RECQL P46063 3/20 0.73
▸ CYP2D6 P10635 2/20 0.73
▸ TDP1 Q9NUW8 2/20 0.73
▸ TERT O14746 12/20 0.69
▸ TP53 P04637 3/20 0.66
▸ MAPK1 P28482 2/20 0.66
▸ BRD4 O60885 1/20 0.66
▸ IKBKB O14920 1/20 0.66
▸ CYP19A1 P11511 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803326 0.88 CYP3A4 (0.83) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL6614129 0.88 HPGD (0.74) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL4625656 0.84 CYP3A4 (1.00) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL6804531 0.81 TERT (0.81) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL6612819 0.80 HPGD (0.68) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL4649959 0.79 TERT (1.00) CYP3A4KDM4EMAPTHPGDALOX15
7,8-Dihydroxyflavone SCHEMBL419316 0.79 TERT (1.00) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL31322174 0.79 TERT (1.00) CYP3A4KDM4EMAPTHPGDALOX15
SCHEMBL35318 0.79 TERT (1.00) CYP3A4KDM4EMAPTHPGDALOX15
7,8-Dihydroxyflavone SCHEMBL29374601 0.79 TERT (1.00) CYP3A4KDM4EMAPTHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2004-04-01 — — US disclosed
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors PHARMACIA ITALIA S.P.A. (IT) 2002-10-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020160983-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP3A4 3385/4885KDM4E 908/4885MAPT 1629/4885
US-20040063665-A1 Substituted benzopyranones as telomerase inhibitors TERT, TERF2, TERF2IP CYP3A4 3411/4885KDM4E 889/4885MAPT 1628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback